Tilo Weiß

3.0k total citations · 2 hit papers
13 papers, 2.5k citations indexed

About

Tilo Weiß is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Tilo Weiß has authored 13 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pharmacology. Recurrent topics in Tilo Weiß's work include Inhalation and Respiratory Drug Delivery (3 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (3 papers). Tilo Weiß is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (3 papers). Tilo Weiß collaborates with scholars based in Germany, France and United States. Tilo Weiß's co-authors include Scott H. Randell, P. Birrer, Robert Tarran, Martina Ulrich, Dieter Worlitzsch, Richard C. Boucher, Keith C. Meyer, K Botzenhart, Ute Schwab and Jürgen Berger and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Tilo Weiß

13 papers receiving 2.5k citations

Hit Papers

Effects of reduced mucus oxygen concentration in airway P... 2002 2026 2010 2018 2002 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tilo Weiß Germany 12 1.5k 1.0k 373 247 243 13 2.5k
Zhan Yang China 32 2.2k 1.5× 639 0.6× 149 0.4× 43 0.2× 97 0.4× 114 3.3k
Mark A. Hancock Canada 25 1.2k 0.8× 224 0.2× 52 0.1× 109 0.4× 76 0.3× 53 2.2k
George M. Hilliard United States 18 1.4k 0.9× 270 0.3× 235 0.6× 18 0.1× 228 0.9× 24 2.3k
Robert Wilson United States 23 1.3k 0.8× 474 0.5× 122 0.3× 25 0.1× 58 0.2× 57 2.3k
Kazuhisa Okada Japan 20 459 0.3× 560 0.5× 131 0.4× 49 0.2× 653 2.7× 71 1.9k
Paola Melotti Italy 24 944 0.6× 732 0.7× 57 0.2× 32 0.1× 51 0.2× 97 2.3k
Yanqi Li China 19 606 0.4× 164 0.2× 199 0.5× 45 0.2× 108 0.4× 50 1.2k
Li Z China 21 907 0.6× 223 0.2× 74 0.2× 42 0.2× 46 0.2× 286 2.0k
Henrieta Škovierová Slovakia 19 621 0.4× 114 0.1× 81 0.2× 218 0.9× 91 0.4× 41 1.5k
Qixiang Shao China 27 1.4k 0.9× 169 0.2× 74 0.2× 56 0.2× 43 0.2× 108 2.9k

Countries citing papers authored by Tilo Weiß

Since Specialization
Citations

This map shows the geographic impact of Tilo Weiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilo Weiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilo Weiß more than expected).

Fields of papers citing papers by Tilo Weiß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilo Weiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilo Weiß. The network helps show where Tilo Weiß may publish in the future.

Co-authorship network of co-authors of Tilo Weiß

This figure shows the co-authorship network connecting the top 25 collaborators of Tilo Weiß. A scholar is included among the top collaborators of Tilo Weiß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilo Weiß. Tilo Weiß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Halland, Nis, Friedemann Schmidt, Tilo Weiß, et al.. (2021). Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry. 65(2). 1567–1584. 9 indexed citations
2.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
3.
Elvert, Ralf, Martin Bossart, Andreas W. Herling, et al.. (2018). Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys. Endocrinology. 159(8). 3105–3119. 19 indexed citations
4.
Halland, Nis, Friedemann Schmidt, Tilo Weiß, et al.. (2014). Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors. ACS Medicinal Chemistry Letters. 6(1). 73–78. 34 indexed citations
5.
Zech, Gernot, Gerhard Heßler, Andreas Evers, et al.. (2012). Identification of High-Affinity P2Y12Antagonists Based on a Phenylpyrazole Glutamic Acid Piperazine Backbone. Journal of Medicinal Chemistry. 55(20). 8615–8629. 30 indexed citations
6.
Aigner, Thomas, Katrin Fundel, Joachim Saas, et al.. (2006). Large‐scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis & Rheumatism. 54(11). 3533–3544. 285 indexed citations
7.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 778 indexed citations breakdown →
8.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 919 indexed citations breakdown →
9.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 80 indexed citations
10.
Weiß, Tilo, et al.. (1999). Monolayers of Cyclopeptides: A New Concept for Molecular Recognition and Enantiomeric Discrimination. Advanced Materials. 11(4). 331–335. 11 indexed citations
11.
Wajant, Harald, Franz‐Josef Johannes, Elvira Haas, et al.. (1998). Dominant-negative FADD inhibits TNFR60-, Fas/Apo1-  and TRAIL-R/Apo2-mediated cell death but not gene induction. Current Biology. 8(2). 113–116. 135 indexed citations
12.
Weiß, Tilo, Matthias Grell, Frank Mühlenbeck, et al.. (1998). TNFR80-Dependent Enhancement of TNFR60-Induced Cell Death Is Mediated by TNFR-Associated Factor 2 and Is Specific for TNFR60. The Journal of Immunology. 161(6). 3136–3142. 116 indexed citations
13.
Rickert, Jan, Tilo Weiß, Wolfgang Kraas, Günther Jung, & Wolfgang Göpel. (1996). A new affinity biosensor: self-assembled thiols as selective monolayer coatings of quartz crystal microbalances. Biosensors and Bioelectronics. 11(6-7). 591–598. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026